I know LL's target more on inflammation. Loss of tissue, is a whole other animal, I would imagine. DR's please chime in here, would love to hear your opinion on this. Lets hope those biomarkers get us a nice direction for PH3 when it gets the rubber stamp. Interesting read, thanks for posting BBNCT.
News 
Market Data 
Discover 
